Superworth

Cosmos Health price to book ratio COSM

Market value divided by the book value of the company's net assets, since 2014.

Today, Oct 23, 2026
1.3×
8-year median
0.8×
Against its 8-year history
66th
percentile: 0 is its lowest day, 100 its highest
8-year range
0.1× to 190×
Peer median
1.9×

Cosmos Health's price to book ratio is 1.3× as of Oct 23, 2026.

That is above its 8-year median of 0.8×, higher than on 66% of days in the last 8 years.

Over that time it ranged from 0.1× in Apr 2024 to 190× in Oct 2021.

The median for 10 healthcare stocks of a similar size is 1.9×.

Price to book ratio over time

The dashed line is the 8-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far1.3×0.5×1.8×
20250.8×0.2×1.2×
20240.5×0.1×0.7×
20230.4×0.2×6.4×
20224.4×0.4×22.4×
202112.3×12.3×190×
2020n/m a value too high to mean anything
201914.0×11.8×15.9×
201821.4×14.2×29.2×
2017n/m a value too high to mean anything
201616.7×12.4×21.0×
201521.1×9.0×24.6×
201419.8×19.8×94.2×

Against its peers

Companies in Healthcare nearest Cosmos Health's size, closest first, today.

CompanyPrice to book ratio
COSMCosmos Health1.3×
NEPHNephros3.2×
ATNMActinium Pharmaceuticals1.6×
APTAlpha Pro Tech0.9×
SPROSpero Therapeutics1.5×
LFVNLifevantage2.2×
ICCCImmucell3.0×
KEQUKewaunee Scientific1.3×
PDEXPro DEX4.2×
PLXProtalix BioTherapeutics2.9×
NATRNatures Sunshine Products1.3×
Peer median1.9×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Cosmos Health

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.